Bavencio (avelumab)
Drug company: EMD Serono
844-826-8371
EMD Serono offers 2 financial assistance programs for patients using Bavencio:
CoverOne Co-Pay Assistance Program
CoverOne Patient Assistance Program
Erivedge (vismodegib) Capsules
Drug company: Genentech
866-422-2377
Genentech Oncology offers 2 financial assistance programs for patients using Erivedge:
Genentech Oncology Co-pay Assistance Program
Genentech Patient Foundation
Keytruda (pembrolizumab)
Drug company: Merck
855-257-3932
Merck offers 2 financial assistance programs for patients using Keytruda:
Genentech Oncology Co-pay Assistance Program
Merck Patient Assistance Program
Libtayo (cemiplimab-rwlc) Injection
Drug company: Regeneron/Sanofi Genzyme
877-542-8296
Regeneron and Sanofi Genzyme, through Libtayo Surround, offer 2 financial assistance programs for patients who have been prescribed Libtayo:
Libtayo Surround Commercial Copay Program
Libtayo Surround Patient Assistance Program
Odomzo (sonidegib) Capsules
Drug company: Sun Pharma
844-563-6696
Sun Pharma provides 2 financial assistance programs for patients using Odomzo:
Odomzo Co-Pay Program
Odomzo Patient Assistance Program
Tazverik (tazemetostat) Tablets
Drug company: Epizyme
833-437-4669
Epizyme offers 4 financial assistance programs for patients who are prescribed Tazverik:
Co-Pay Assistance Program
Patient Assistance Program
Bridge Supply Program
Quick Start Program
Table. Drugs Prescribed for Skin Cancer/Merkel-Cell Carcinoma
- Drug name (generic name)
- Drug company
- Indications
- Patient support services
- Bavencio (avelumab)
- EMD Serono
- Treatment of metastatic Merkel-cell carcinoma, a type of skin cancer
- CoverOne Co-Pay Assistance Program
844-826-8371
CoverOne Patient Assistance Program
844-826-8371
Drug name (generic name)
Drug company
Indications
Patient support services
- Erivedge (vismodegib) Capsules
- Genentech
- Treatment of locally advanced or metastatic basal-cell carcinoma
- Genentech Oncology Co-pay Assistance Program
855-692-6729
Genentech Patient Foundation
888-941-3331
Drug name (generic name)
Drug company
Indications
Patient support services
- Keytruda (pembrolizumab)
- Merck
- Treatment of recurrent
locally advanced or
metastatic Merkel-cell
carcinoma, a type of
skin cancer
Treatment of recurrent or metastatic cutaneous squamous-cell carcinoma that cannot be cured by surgery or radiation - Merck Co-pay Assistance Program
855-257-3932
Merck Patient Assistance Program
855-257-3932
Drug name (generic name)
Drug company
Indications
Patient support services
- Libtayo (cemiplimab-rwlc) Injection
- Regeneron/Sanofi Genzyme
- Metastatic cutaneous
squamous-cell
carcinoma (CSCC) or
locally advanced CSCC
Treatment of locally advanced or metastatic basal-cell carcinoma in patients who were previously treated with a hedgehog inhibitor or are not eligible to use a hedgehog inhibitor - Libtayo Surround Commercial Copay Program
877-542-8296
Libtayo Surround Patient Assistance Program
877-542-8296
Drug name (generic name)
Drug company
Indications
Patient support services
- Odomzo (sonidegib) Capsules
- Sun Pharma
- Locally advanced basalcell carcinoma that relapsed after surgery or radiation or cannot be removed by surgery or radiation
- Odomzo Co-Pay Program
877-636-6961
Odomzo Patient Access Program
844-563-6696
Drug name (generic name)
Drug company
Indications
Patient support services
- Tazverik (tazemetostat) Tablets
- Epizyme
- Treatment of locally advanced or metastatic epithelioid carcinoma in patients 16 years or older who are not eligible for surgery
- Co-Pay Assistance Program
833-437-4669
Patient Assistance Program
833-437-4669
Bridge Supply Program
833-437-4669
Quick Start Program
833-437-4669
Drug name (generic name)
Drug company
Indications
Patient support services